<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>SPECIFIC CHARACTERISTICS OF IMMUNOGLOBULIN E IN VIRAL ALLERGODERMATOSES IN CHILDREN</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">KHUDAYBERGANOV MUNIS</mods:namePart><mods:namePart type="family">RUZIBAEVICH</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">NAVRUZOVA SHAKAR</mods:namePart><mods:namePart type="family">ISTAMOVNA</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Modern scientific achievements allow us to better understand the mechanisms of inflammation and the involvement of the immune system in the co-occurrence of allergic and infectious diseases. However, classical treatment regimens for allergic dermatoses are often ineffective in cases associated with viruses. Therefore, there is a need to search for new clinical and laboratory markers and methods of differentiated therapy. The issue of determining CMV/HSV status and immunological indicators, “…optimizing diagnostic methods for viral allergic dermatoses in early childhood” is becoming increasingly urgent and necessary.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-11-06</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>